PAR2

PAR2

PAR2 詳細

Molecule Name
Protease-activated receptor-2
分子の別称
PAR2
Drug Development Progress
治験薬の数3
市販薬剤の数0
研究&開発段階Phase 2 Clinical
ターゲットの別称
Receptor, PAR-2,F2RL1,Thrombin receptor-like 1,G-protein coupled receptor 11,F2R Like Trypsin Receptor 1,PAR2,GPR11,Protease-Activated Receptor 2,Coagulation Factor II (Thrombin) Receptor-Like 1,Proteinase-Activated Receptor-2,Proteinase-activated receptor 2,Coagulation factor II receptor-like 1
バックグランド
This gene encodes a member of the G-protein coupled receptor 1 family of proteins. The encoded cell surface receptor is activated through proteolytic cleavage of its extracellular amino terminus, resulting in a new amino terminus that acts as a tethered ligand that binds to an extracellular loop domain. Activation of the receptor has been shown to stimulate vascular smooth muscle relaxation, dilate blood vessels, increase blood flow, and lower blood pressure. This protein is also important in the inflammatory response, as well as innate and adaptive immunity. [provided by RefSeq, Jun 2016]

PAR2 製品リスト

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
MEDI-0618MEDI-0618; MEDI0618; ABBV-2002; ABBV2002Phase 2 ClinicalAstrazeneca Plc
Chronic Pain; Migraine Disorders
詳細
TEV-56192TEV-56192Phase 1 ClinicalTeva Pharmaceutical Industries Ltd
Nervous System Diseases
詳細
OA-235iOA-235iPhase 1 ClinicalOasis Pharmaceuticals LLC
Metabolic Dysfunction-Associated Steatotic Liver Disease
詳細